Resource Summary

Clinical Question:
Does treating type 2 diabetes with sulfonylureas affect mortality or cardiovascular events?
Bottom Line:
There is a lack of convincing evidence that sulfonylureas reduce cardiovascular events or mortality in type 2 diabetic patients. If anything^ sulfonylureas potentially increase cardiovascular harm.

Publication Date: 2018-1-2
Last Updated on PCR: 2018-01-03 18:46:30